APO Research
Talk to an analyst

APO RESEARCH · REPORT

Paclitaxel and Docetaxel APIs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Paclitaxel and Docetaxel APIs Industry Growth and Trends Forecast to 2032

28 December 202598 pages

Choose your research edition.

Industry ResearchPaclitaxel and Docetaxel APIs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Paclitaxel and Docetaxel APIs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Paclitaxel and Docetaxel APIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paclitaxel and Docetaxel APIs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Paclitaxel and Docetaxel APIs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Paclitaxel and Docetaxel APIs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Paclitaxel and Docetaxel APIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Paclitaxel and Docetaxel APIs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Paclitaxel and Docetaxel APIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Paclitaxel and Docetaxel APIs include Indena, Phyton Biotech, Samyang Biopharm, ScinoPharm, Teva API, Fujian South Pharmaceutical, Guilin Huiang Biochemical Pharmaceutical, Taxus Pharma and Yunnan Hande, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Paclitaxel and Docetaxel APIs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Paclitaxel and Docetaxel APIs market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Paclitaxel and Docetaxel APIs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Paclitaxel and Docetaxel APIs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Paclitaxel and Docetaxel APIs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Paclitaxel and Docetaxel APIs Market by Company

Indena

Phyton Biotech

Samyang Biopharm

ScinoPharm

Teva API

Fujian South Pharmaceutical

Guilin Huiang Biochemical Pharmaceutical

Taxus Pharma

Yunnan Hande

Paclitaxel and Docetaxel APIs Segment by Type

Paclitaxel API

Docetaxel API

Paclitaxel and Docetaxel APIs Segment by Application

Paclitaxel Injection

Paclitaxel Liposomes

Docetaxel Injection

Nab-paclitaxel

Paclitaxel and Docetaxel APIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paclitaxel and Docetaxel APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paclitaxel and Docetaxel APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paclitaxel and Docetaxel APIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paclitaxel and Docetaxel APIs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Paclitaxel and Docetaxel APIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Paclitaxel API Table 2. Major Company of Docetaxel API Table 3. Global Paclitaxel and Docetaxel APIs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (Kg) Table 5. Global Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Paclitaxel and Docetaxel APIs Sales Market Share in Value by Type (2021-2026) Table 8. Global Paclitaxel and Docetaxel APIs Price by Type (2021-2026) & (US$/Kg) Table 9. Global Paclitaxel and Docetaxel APIs Sales by Type (2027-2032) & (Kg) Table 10. Global Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Paclitaxel and Docetaxel APIs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Paclitaxel and Docetaxel APIs Sales Market Share in Value by Type (2027-2032) Table 13. Global Paclitaxel and Docetaxel APIs Price by Type (2027-2032) & (US$/Kg) Table 14. North America Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (Kg) Table 15. North America Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (Kg) Table 17. Europe Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (Kg) Table 21. Latin America Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Type (2021-2026) & (US$ Million) Table 24. Paclitaxel and Docetaxel APIs Industry Trends Table 25. Paclitaxel and Docetaxel APIs Industry Drivers Table 26. Paclitaxel and Docetaxel APIs Industry Opportunities and Challenges Table 27. Paclitaxel and Docetaxel APIs Industry Restraints Table 28. Global Paclitaxel and Docetaxel APIs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Company (2021-2026) Table 30. Global Paclitaxel and Docetaxel APIs Sales by Company (2021-2026) & (Kg) Table 31. Global Paclitaxel and Docetaxel APIs Sales Share by Company (2021-2026) Table 32. Global Paclitaxel and Docetaxel APIs Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Paclitaxel and Docetaxel APIs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Paclitaxel and Docetaxel APIs Major Company Production Sites and Headquarters Table 35. Global Paclitaxel and Docetaxel APIs Company, Product Type & Application Table 36. Global Paclitaxel and Docetaxel APIs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Paclitaxel and Docetaxel APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Paclitaxel and Docetaxel APIs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Paclitaxel and Docetaxel APIs Sales by Region (2021-2026) & (Kg) Table 41. Global Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Paclitaxel and Docetaxel APIs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Paclitaxel and Docetaxel APIs Sales Market Share in Value by Region (2021-2026) Table 44. Global Paclitaxel and Docetaxel APIs Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Paclitaxel and Docetaxel APIs Sales by Region (2027-2032) & (Kg) Table 46. Global Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Paclitaxel and Docetaxel APIs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Paclitaxel and Docetaxel APIs Sales Market Share in Value by Region (2027-2032) Table 49. Global Paclitaxel and Docetaxel APIs Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Paclitaxel and Docetaxel APIs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (Kg) Table 52. Global Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Paclitaxel and Docetaxel APIs Sales Market Share in Value by Application (2021-2026) Table 55. Global Paclitaxel and Docetaxel APIs Price by Application (2021-2026) & (US$/Kg) Table 56. Global Paclitaxel and Docetaxel APIs Sales by Application (2027-2032) & (Kg) Table 57. Global Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Paclitaxel and Docetaxel APIs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Paclitaxel and Docetaxel APIs Sales Market Share in Value by Application (2027-2032) Table 60. Global Paclitaxel and Docetaxel APIs Price by Application (2027-2032) & (US$/Kg) Table 61. North America Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (Kg) Table 62. North America Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (Kg) Table 64. Europe Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (Kg) Table 68. Latin America Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Application (2021-2026) & (US$ Million) Table 71. Indena Company Information Table 72. Indena Business Overview Table 73. Indena Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Indena Paclitaxel and Docetaxel APIs Product Portfolio Table 75. Indena Recent Development Table 76. Phyton Biotech Company Information Table 77. Phyton Biotech Business Overview Table 78. Phyton Biotech Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Phyton Biotech Paclitaxel and Docetaxel APIs Product Portfolio Table 80. Phyton Biotech Recent Development Table 81. Samyang Biopharm Company Information Table 82. Samyang Biopharm Business Overview Table 83. Samyang Biopharm Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Samyang Biopharm Paclitaxel and Docetaxel APIs Product Portfolio Table 85. Samyang Biopharm Recent Development Table 86. ScinoPharm Company Information Table 87. ScinoPharm Business Overview Table 88. ScinoPharm Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. ScinoPharm Paclitaxel and Docetaxel APIs Product Portfolio Table 90. ScinoPharm Recent Development Table 91. Teva API Company Information Table 92. Teva API Business Overview Table 93. Teva API Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Teva API Paclitaxel and Docetaxel APIs Product Portfolio Table 95. Teva API Recent Development Table 96. Fujian South Pharmaceutical Company Information Table 97. Fujian South Pharmaceutical Business Overview Table 98. Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Product Portfolio Table 100. Fujian South Pharmaceutical Recent Development Table 101. Guilin Huiang Biochemical Pharmaceutical Company Information Table 102. Guilin Huiang Biochemical Pharmaceutical Business Overview Table 103. Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Product Portfolio Table 105. Guilin Huiang Biochemical Pharmaceutical Recent Development Table 106. Taxus Pharma Company Information Table 107. Taxus Pharma Business Overview Table 108. Taxus Pharma Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. Taxus Pharma Paclitaxel and Docetaxel APIs Product Portfolio Table 110. Taxus Pharma Recent Development Table 111. Yunnan Hande Company Information Table 112. Yunnan Hande Business Overview Table 113. Yunnan Hande Paclitaxel and Docetaxel APIs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. Yunnan Hande Paclitaxel and Docetaxel APIs Product Portfolio Table 115. Yunnan Hande Recent Development Table 116. North America Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 117. North America Paclitaxel and Docetaxel APIs Sales by Country (2021-2026) & (Kg) Table 118. North America Paclitaxel and Docetaxel APIs Sales Market Share by Country (2021-2026) Table 119. North America Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032) & (Kg) Table 120. North America Paclitaxel and Docetaxel APIs Sales Market Share Forecast by Country (2027-2032) Table 121. North America Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Paclitaxel and Docetaxel APIs Market Share by Country (2021-2026) Table 124. North America Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Paclitaxel and Docetaxel APIs Market Share Forecast by Country (2027-2032) Table 126. Europe Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 127. Europe Paclitaxel and Docetaxel APIs Sales by Country (2021-2026) & (Kg) Table 128. Europe Paclitaxel and Docetaxel APIs Sales Market Share by Country (2021-2026) Table 129. Europe Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032) & (Kg) Table 130. Europe Paclitaxel and Docetaxel APIs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Paclitaxel and Docetaxel APIs Market Share by Country (2021-2026) Table 134. Europe Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Paclitaxel and Docetaxel APIs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Paclitaxel and Docetaxel APIs Sales by Country (2021-2026) & (Kg) Table 138. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032) & (Kg) Table 140. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Paclitaxel and Docetaxel APIs Market Share by Country (2021-2026) Table 144. Asia-Pacific Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Paclitaxel and Docetaxel APIs Market Share Forecast by Country (2027-2032) Table 146. Latin America Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. Latin America Paclitaxel and Docetaxel APIs Sales by Country (2021-2026) & (Kg) Table 148. Latin America Paclitaxel and Docetaxel APIs Sales Market Share by Country (2021-2026) Table 149. Latin America Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032) & (Kg) Table 150. Latin America Paclitaxel and Docetaxel APIs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Paclitaxel and Docetaxel APIs Market Share by Country (2021-2026) Table 154. Latin America Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Paclitaxel and Docetaxel APIs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Country (2021-2026) & (Kg) Table 158. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032) & (Kg) Table 160. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Paclitaxel and Docetaxel APIs Market Share by Country (2021-2026) Table 164. Middle East and Africa Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Paclitaxel and Docetaxel APIs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Paclitaxel and Docetaxel APIs Distributors List Table 169. Paclitaxel and Docetaxel APIs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Paclitaxel and Docetaxel APIs Image Figure 2. Global Paclitaxel and Docetaxel APIs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paclitaxel and Docetaxel APIs Market Size (2021-2032) & (US$ Million) Figure 4. Global Paclitaxel and Docetaxel APIs Sales (2021-2032) & (Kg) Figure 5. Paclitaxel API Image Figure 6. Global Paclitaxel API Sales YoY Growth (2021-2032) & (Kg) Figure 7. Docetaxel API Image Figure 8. Global Docetaxel API Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Paclitaxel and Docetaxel APIs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Paclitaxel and Docetaxel APIs Market Share by Type 2025 VS 2032 Figure 11. North America Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Type in 2025 Figure 12. North America Paclitaxel and Docetaxel APIs Sales Market Share in Value by Type in 2025 Figure 13. Europe Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Paclitaxel and Docetaxel APIs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Paclitaxel and Docetaxel APIs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Paclitaxel and Docetaxel APIs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Paclitaxel Injection Image Figure 24. Global Paclitaxel Injection Sales YoY Growth (2021-2032) & (Kg) Figure 25. Paclitaxel Liposomes Image Figure 26. Global Paclitaxel Liposomes Sales YoY Growth (2021-2032) & (Kg) Figure 27. Docetaxel Injection Image Figure 28. Global Docetaxel Injection Sales YoY Growth (2021-2032) & (Kg) Figure 29. Nab-paclitaxel Image Figure 30. Global Nab-paclitaxel Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Paclitaxel and Docetaxel APIs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Paclitaxel and Docetaxel APIs Market Share by Application 2025 VS 2032 Figure 33. North America Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Application in 2025 Figure 34. North America Paclitaxel and Docetaxel APIs Sales Market Share in Value by Application in 2025 Figure 35. Europe Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Paclitaxel and Docetaxel APIs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Paclitaxel and Docetaxel APIs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Market Share in Value by Application in 2025 Figure 43. North America Paclitaxel and Docetaxel APIs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Paclitaxel and Docetaxel APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Paclitaxel and Docetaxel APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Paclitaxel and Docetaxel APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Paclitaxel and Docetaxel APIs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Paclitaxel and Docetaxel APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Paclitaxel and Docetaxel APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Paclitaxel and Docetaxel APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Paclitaxel and Docetaxel APIs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Paclitaxel and Docetaxel APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Paclitaxel and Docetaxel APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Paclitaxel and Docetaxel APIs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Paclitaxel and Docetaxel APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Paclitaxel and Docetaxel APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Paclitaxel and Docetaxel APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Paclitaxel and Docetaxel APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Paclitaxel and Docetaxel APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Paclitaxel and Docetaxel APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Paclitaxel and Docetaxel APIs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Paclitaxel and Docetaxel APIs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Paclitaxel API
  • Docetaxel API
Applications
  • Paclitaxel Injection
  • Paclitaxel Liposomes
  • Docetaxel Injection
  • Nab-paclitaxel
Companies covered
  • Indena
  • Phyton Biotech
  • Samyang Biopharm
  • ScinoPharm
  • Teva API
  • Fujian South Pharmaceutical
  • Guilin Huiang Biochemical Pharmaceutical
  • Taxus Pharma
  • Yunnan Hande

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Paclitaxel and Docetaxel APIs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Paclitaxel and Docetaxel APIs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Paclitaxel and Docetaxel APIs Market by Type
  6. 1.3.1 Paclitaxel API
  7. 1.3.2 Docetaxel API
  8. 1.4 Global Paclitaxel and Docetaxel APIs Market Size by Type
  9. 1.4.1 Global Paclitaxel and Docetaxel APIs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Paclitaxel and Docetaxel APIs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Paclitaxel and Docetaxel APIs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Paclitaxel and Docetaxel APIs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Paclitaxel and Docetaxel APIs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Paclitaxel and Docetaxel APIs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Paclitaxel and Docetaxel APIs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Paclitaxel and Docetaxel APIs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Paclitaxel and Docetaxel APIs Industry Trends
  2. 2.2 Paclitaxel and Docetaxel APIs Industry Drivers
  3. 2.3 Paclitaxel and Docetaxel APIs Industry Opportunities and Challenges
  4. 2.4 Paclitaxel and Docetaxel APIs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Paclitaxel and Docetaxel APIs Revenue (2021-2026)
  2. 3.2 Global Top Players by Paclitaxel and Docetaxel APIs Sales (2021-2026)
  3. 3.3 Global Top Players by Paclitaxel and Docetaxel APIs Price (2021-2026)
  4. 3.4 Global Paclitaxel and Docetaxel APIs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Paclitaxel and Docetaxel APIs Major Company Production Sites & Headquarters
  6. 3.6 Global Paclitaxel and Docetaxel APIs Company, Product Type & Application
  7. 3.7 Global Paclitaxel and Docetaxel APIs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Paclitaxel and Docetaxel APIs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Paclitaxel and Docetaxel APIs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Paclitaxel and Docetaxel APIs Tier 1, Tier 2, and Tier 3
4 Paclitaxel and Docetaxel APIs Regional Status and Outlook
  1. 4.1 Global Paclitaxel and Docetaxel APIs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Paclitaxel and Docetaxel APIs Historic Market Size by Region
  3. 4.2.1 Global Paclitaxel and Docetaxel APIs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Paclitaxel and Docetaxel APIs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Paclitaxel and Docetaxel APIs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Paclitaxel and Docetaxel APIs Forecasted Market Size by Region
  7. 4.3.1 Global Paclitaxel and Docetaxel APIs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Paclitaxel and Docetaxel APIs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Paclitaxel and Docetaxel APIs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Paclitaxel and Docetaxel APIs by Application
  1. 5.1 Paclitaxel and Docetaxel APIs Market by Application
  2. 5.1.1 Paclitaxel Injection
  3. 5.1.2 Paclitaxel Liposomes
  4. 5.1.3 Docetaxel Injection
  5. 5.1.4 Nab-paclitaxel
  6. 5.2 Global Paclitaxel and Docetaxel APIs Market Size by Application
  7. 5.2.1 Global Paclitaxel and Docetaxel APIs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Paclitaxel and Docetaxel APIs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Paclitaxel and Docetaxel APIs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Paclitaxel and Docetaxel APIs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Paclitaxel and Docetaxel APIs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Paclitaxel and Docetaxel APIs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Paclitaxel and Docetaxel APIs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Paclitaxel and Docetaxel APIs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Indena
  2. 6.1.1 Indena Company Information
  3. 6.1.2 Indena Business Overview
  4. 6.1.3 Indena Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Indena Paclitaxel and Docetaxel APIs Product Portfolio
  6. 6.1.5 Indena Recent Developments
  7. 6.2 Phyton Biotech
  8. 6.2.1 Phyton Biotech Company Information
  9. 6.2.2 Phyton Biotech Business Overview
  10. 6.2.3 Phyton Biotech Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Phyton Biotech Paclitaxel and Docetaxel APIs Product Portfolio
  12. 6.2.5 Phyton Biotech Recent Developments
  13. 6.3 Samyang Biopharm
  14. 6.3.1 Samyang Biopharm Company Information
  15. 6.3.2 Samyang Biopharm Business Overview
  16. 6.3.3 Samyang Biopharm Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Samyang Biopharm Paclitaxel and Docetaxel APIs Product Portfolio
  18. 6.3.5 Samyang Biopharm Recent Developments
  19. 6.4 ScinoPharm
  20. 6.4.1 ScinoPharm Company Information
  21. 6.4.2 ScinoPharm Business Overview
  22. 6.4.3 ScinoPharm Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ScinoPharm Paclitaxel and Docetaxel APIs Product Portfolio
  24. 6.4.5 ScinoPharm Recent Developments
  25. 6.5 Teva API
  26. 6.5.1 Teva API Company Information
  27. 6.5.2 Teva API Business Overview
  28. 6.5.3 Teva API Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva API Paclitaxel and Docetaxel APIs Product Portfolio
  30. 6.5.5 Teva API Recent Developments
  31. 6.6 Fujian South Pharmaceutical
  32. 6.6.1 Fujian South Pharmaceutical Company Information
  33. 6.6.2 Fujian South Pharmaceutical Business Overview
  34. 6.6.3 Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Product Portfolio
  36. 6.6.5 Fujian South Pharmaceutical Recent Developments
  37. 6.7 Guilin Huiang Biochemical Pharmaceutical
  38. 6.7.1 Guilin Huiang Biochemical Pharmaceutical Company Information
  39. 6.7.2 Guilin Huiang Biochemical Pharmaceutical Business Overview
  40. 6.7.3 Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Product Portfolio
  42. 6.7.5 Guilin Huiang Biochemical Pharmaceutical Recent Developments
  43. 6.8 Taxus Pharma
  44. 6.8.1 Taxus Pharma Company Information
  45. 6.8.2 Taxus Pharma Business Overview
  46. 6.8.3 Taxus Pharma Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Taxus Pharma Paclitaxel and Docetaxel APIs Product Portfolio
  48. 6.8.5 Taxus Pharma Recent Developments
  49. 6.9 Yunnan Hande
  50. 6.9.1 Yunnan Hande Company Information
  51. 6.9.2 Yunnan Hande Business Overview
  52. 6.9.3 Yunnan Hande Paclitaxel and Docetaxel APIs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Yunnan Hande Paclitaxel and Docetaxel APIs Product Portfolio
  54. 6.9.5 Yunnan Hande Recent Developments
7 North America by Country
  1. 7.1 North America Paclitaxel and Docetaxel APIs Sales by Country
  2. 7.1.1 North America Paclitaxel and Docetaxel APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Paclitaxel and Docetaxel APIs Sales by Country (2021-2026)
  4. 7.1.3 North America Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Paclitaxel and Docetaxel APIs Market Size by Country
  6. 7.2.1 North America Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026)
  8. 7.2.3 North America Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Paclitaxel and Docetaxel APIs Sales by Country
  2. 8.1.1 Europe Paclitaxel and Docetaxel APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Paclitaxel and Docetaxel APIs Sales by Country (2021-2026)
  4. 8.1.3 Europe Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Paclitaxel and Docetaxel APIs Market Size by Country
  6. 8.2.1 Europe Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Paclitaxel and Docetaxel APIs Sales by Country
  2. 9.1.1 Asia-Pacific Paclitaxel and Docetaxel APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Paclitaxel and Docetaxel APIs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Paclitaxel and Docetaxel APIs Market Size by Country
  6. 9.2.1 Asia-Pacific Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Paclitaxel and Docetaxel APIs Sales by Country
  2. 10.1.1 South America Paclitaxel and Docetaxel APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Paclitaxel and Docetaxel APIs Sales by Country (2021-2026)
  4. 10.1.3 South America Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Paclitaxel and Docetaxel APIs Market Size by Country
  6. 10.2.1 South America Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026)
  8. 10.2.3 South America Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Country
  2. 11.1.1 Middle East and Africa Paclitaxel and Docetaxel APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Paclitaxel and Docetaxel APIs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Paclitaxel and Docetaxel APIs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Paclitaxel and Docetaxel APIs Market Size by Country
  6. 11.2.1 Middle East and Africa Paclitaxel and Docetaxel APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Paclitaxel and Docetaxel APIs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Paclitaxel and Docetaxel APIs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Paclitaxel and Docetaxel APIs Value Chain Analysis
  2. 12.1.1 Paclitaxel and Docetaxel APIs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Paclitaxel and Docetaxel APIs Production Mode & Process
  7. 12.2 Paclitaxel and Docetaxel APIs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Paclitaxel and Docetaxel APIs Distributors
  10. 12.2.3 Paclitaxel and Docetaxel APIs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst